MultNAT® HPV Panel
Product Overview
MultNAT® HPV Panel is an automated, in vitro nucleic acid amplification test used to qualitatively detect the E6/E7 gene region of the viral DNA genome from high risk Human Papillomavirus (HPV) in Cervical specimens. The test carries out multiplexed amplification of target DNA of 14 HPV types including HPV16, HPV18, HPV31, HPV33, HPV35, HPV39, HPV45, HPV51, HPV52, HPV56, HPV58, HPV59, HPV66, HPV68 in a single analysis.
This kit can be used with a Pap specimen to assess the presence or absence of 14 HPV genotypes in adult females who are at increased risk of developing cervical cancer or presence high-grade disease. This kit can also be used as a first-line primary screening test to identify adult females who are at increased risk of developing cervical cancer or the presence of high-grade disease.
- Fast: Get result from sample in about 58 minutes
- Simple: Fully automated workflow. Sample-in, result-out
- Safe: All-in-one cartridge with integrated UDG anti-contamination system
- Accuracy: high sensitivity, high specificity ensures precise pathogen identification
Clinical Value
Cervical cancer, caused almost exclusively by oncogenic types of HPV, is an important public health problem globally. In 2020, an estimated 604,000 women were diagnosed with cervical cancer worldwide. By 2022, this data has increased to 662,000 and approximately 34,000 women died from the disease.
- Asymptomatic carrier: posing great difficulties for clinical management-without regular screening, asymptomatic carriers may become silent sources of transmission
- Multiple Subtypes, Single Sample: The dilemma of mixed Infections and multiplex detection
- Complex Testing Workflow: Multiple limitations of traditional methods
Ongoing Challenges
- Affordable POC viral load tests, cost-effective for low- and medium-income countries.
- Standardized guidelines for managing low-level viremia.
- Fully closed test cartridge design. No cross-contamination.
